Compounds > cefotiam
Page last updated: 2024-08-23

cefotiam and arbekacin

cefotiam has been researched along with arbekacin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Nakane, Y; Oda, S; Suzuki, Y; Yokota, N1
Kanno, M; Kawabata, T; Sobu, K; Takase, Y; Watanabe, T; Yoshida, T1
Arakawa, K; Kono, K; Takeda, S; Tatara, I1
Hori, K; Ishikawa, S; Mashita, K; Mizuno, A; Shinagawa, N; Yura, J1
Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Suzuki, K; Suzuki, Y; Yokota, N1

Other Studies

5 other study(ies) available for cefotiam and arbekacin

ArticleYear
[Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. III. Combined effects of arbekacin with cefotiam or cefuzonam].
    The Japanese journal of antibiotics, 1992, Volume: 45, Issue:10

    Topics: Aminoglycosides; Anti-Bacterial Agents; Cefotiam; Ceftizoxime; Dibekacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Synergism; Methicillin Resistance; Staphylococcus aureus

1992
[Basic studies on combination effects of arbekacin and beta-lactam antibiotics on methicillin-resistant Staphylococcus aureus].
    The Japanese journal of antibiotics, 1994, Volume: 47, Issue:6

    Topics: Aminoglycosides; Anti-Bacterial Agents; Cefotiam; Cephalosporins; Cilastatin; Dibekacin; Drug Therapy, Combination; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus

1994
In vitro activities of arbekacin, alone and in combination, against methicillin-resistant Staphylococcus aureus.
    The Japanese journal of antibiotics, 1994, Volume: 47, Issue:6

    Topics: Aminoglycosides; Anti-Bacterial Agents; Cefotiam; Ceftizoxime; Cephalosporins; Dibekacin; Drug Therapy, Combination; Fosfomycin; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus

1994
[Efficacy of arbekacin, a new aminoglycoside antibiotic, in surgical patients with MRSA infections].
    The Japanese journal of antibiotics, 1994, Volume: 47, Issue:6

    Topics: Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Cefotiam; Cilastatin; Dibekacin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Methicillin Resistance; Postoperative Complications; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection

1994
[Bacteriological evaluations of combination effects with cefotiam and other antimicrobial agents against methicillin-resistant Staphylococcus aureus. II. Synergistic actions of cefotiam with arbekacin and minocycline].
    The Japanese journal of antibiotics, 1993, Volume: 46, Issue:2

    Topics: Aminoglycosides; Anti-Bacterial Agents; Cefotiam; Dibekacin; Drug Synergism; Drug Therapy, Combination; Methicillin Resistance; Microbial Sensitivity Tests; Minocycline; Staphylococcus aureus

1993